Benzinga | May 6, 2021 05:36PM EDT

Aprea Therapeutics Q1 EPS $(0.46) Down From $(0.45) YoY

Aprea Therapeutics (NASDAQ:APRE) reported quarterly losses of $(0.46) per share. This is a 2.22 percent decrease over losses of $(0.45) per share from the same period last year.